Literature DB >> 20829118

Timing of posterior urethral valve diagnosis and its impact on clinical outcome.

Yusuf Kibar1, Richard A Ashley, Christopher C Roth, Dominic Frimberger, Bradley P Kropp.   

Abstract

OBJECTIVE: Our goals were to assess long-term outcome for patients with posterior urethral valves (PUV) and determine the impact of the timing of diagnosis. PATIENTS AND METHODS: We reviewed the hospital records for patients with PUV treated in 1994-2008. Only those patients diagnosed, treated surgically, and followed clinically at our center were included.
RESULTS: There were 52 patients with PUV. Thirty-nine were diagnosed by 1 year of age (early diagnosis cohort), while 13 were diagnosed after 1 year (late diagnosis cohort). Mean follow up after valve operation was 7.2 years (range 15 months-14 years). Chronic renal failure rates were not statistically different between the early and late diagnosis groups after surgical intervention: 48% (14/29) vs 25% (3/12), P = 0.30. Among the early diagnosis cases, 10% (3/29) eventually required renal transplant, while no child in the late diagnosis group has developed end-stage renal disease to date (P = 0.55).
CONCLUSIONS: Gestational age at diagnosis is an important predictor of postnatal renal outcome. Our results suggest that diagnosis after 1 year of age is associated with a lower risk of developing renal insufficiency on long-term follow up.
Copyright © 2010 Journal of Pediatric Urology Company. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20829118     DOI: 10.1016/j.jpurol.2010.08.002

Source DB:  PubMed          Journal:  J Pediatr Urol        ISSN: 1477-5131            Impact factor:   1.830


  9 in total

1.  Comparison of outcomes of prenatal versus postnatal presentation of posterior urethral valves: a systematic review and meta-analysis.

Authors:  Priyank Yadav; Mandy Rickard; Jin Kyu Kim; Juliane Richter; Marisol Lolas; Dheidan Alshammari; Michael E Chua; Joana Dos Santos; Armando J Lorenzo
Journal:  World J Urol       Date:  2022-08-09       Impact factor: 3.661

2.  Abdominal distention and renal failure in a neonate.

Authors:  Badreldin Bedri; Julie E Goodwin
Journal:  BMJ Case Rep       Date:  2013-02-20

3.  Posterior urethral valves: Risk factors for progression to renal failure.

Authors:  Aylin N Bilgutay; David R Roth; Edmond T Gonzales; Nicolette Janzen; Wei Zhang; Chester J Koh; Patricio Gargollo; Abhishek Seth
Journal:  J Pediatr Urol       Date:  2015-11-26       Impact factor: 1.830

Review 4.  A systematic review on renal and bladder dysfunction after endoscopic treatment of infravesical obstruction in boys.

Authors:  Pauline M L Hennus; Geert J M G van der Heijden; J L H Ruud Bosch; Tom P V M de Jong; Laetitia M O de Kort
Journal:  PLoS One       Date:  2012-09-13       Impact factor: 3.240

5.  Renal outcomes of neonates with early presentation of posterior urethral valves: a 10-year single center experience.

Authors:  Madeline Coquillette; Richard S Lee; Sarah E Pagni; Sule Cataltepe; Deborah R Stein
Journal:  J Perinatol       Date:  2019-08-30       Impact factor: 2.521

6.  Impact of surgical intervention on progression to end-stage renal disease in patients with posterior urethral valve.

Authors:  Rishikesh Velhal; Aadhar Jain; Anveshi Nayan; Sujata Patwardhan; Bhushan Patil
Journal:  Afr J Urol       Date:  2021-12-11

7.  Experience with the use of mohan's valvotome for posterior urethral valve ablation at a centre in North-Eastern Nigeria.

Authors:  Adewale Olaotan Oyinloye; Auwal Mohammed Abubakar; Samuel Wabada; Christopher Uruku Rikin
Journal:  Afr J Paediatr Surg       Date:  2022 Jul-Sep

8.  Posterior urethral valves: Impact of low birth weight and preterm delivery on the final renal outcome.

Authors:  Osama M Sarhan
Journal:  Arab J Urol       Date:  2017-03-07

9.  Short-Term Outcomes of Treatment of Boys with Posterior Urethral Valves.

Authors:  Abdulrasheed A Nasir; Adewale O Oyinloye; Lukman O Abdur-Rahman; Kayode T Bamigbola; Nurudeen T Abdulraheem; Olanrewaju T Adedoyin; James O Adeniran
Journal:  Niger Med J       Date:  2020-02-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.